Akron BioProducts and Vor Bio to develop and cGMP manufacture of nucleases
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies